

Dust allergy occurs when your immune system reacts to specific particles that commonly live in household dust. The immune system mistakenly recognizes these dust particles as harmful (allergens) and produces an inappropriate response by producing antibodies (specific proteins) called Immunoglobulin E (IgE).
The Allergy - Dust Panel, ImmunoCAP is a comprehensive allergy panel that includes the Total IgE test, used to measure the total IgE levels in the blood. In addition, this test also detects the presence of specific IgE antibodies to a wide range of dust allergens, including house dust mites such as D Farinae and D Pteronsysinus, German cockroach and house dust (Greer Labs).
Your doctor may suggest the Allergy - Dust Panel, ImmunoCAP if you exhibit symptoms associated with inhalant allergy such as nasal congestion, sneezing, itchy/watery eyes, coughing, wheezing, skin rashes, hives, etc. Doctors may also perform this test if there are no specific symptoms and cause of the allergy is not clear. Allergen detection through this panel will help your doctor guide appropriate management and treatment decisions and prevent severe complications.
Generally, no special preparation is required for the Allergy - Dust Panel, ImmunoCAP. However, a brief clinical history is preferred before sample collection. Also, inform your doctor about any medications (such as antihistamines) you are taking, as they might influence your test results.
A positive test result signifies sensitivity to one or more common dust allergens, warranting further investigation through more specific allergy testing. Conversely, a negative result indicates no sensitization to the tested allergens, though it does not eliminate the possibility of allergies to other substances not covered in this panel.
Lab test results can vary depending on the specific test kit used, as different methods and the quality of allergens used can affect the quantification of IgE. Therefore, these results are intended to be interpreted in conjunction with clinical symptoms.
The Allergy - Dust Panel, ImmunoCAP measures total and specific immunoglobulin E (IgE) antibodies in the blood associated with allergic reactions to dust allergens. This comprehensive panel includes house dust mites such as D Farinae and D Pteronsysinus, German Cockroach and House Dust (Greer Labs). This panel utilized the ImmunoCAP assay, a highly accurate and sensitive procedure that provides quantitative measurement of IgE antibodies and helps diagnose dust allergies and assess their severity.
The D Farinae test measures the presence and levels of specific IgE antibodies produced by the immune system in response to allergens from Dermatophagoides farinae mites (a common house dust mite). The test helps evaluate the body's immune response to dust mites, which are often found in home environments. Elevated IgE levels in response to these mites indicate an allergic sensitivity, enabling doctors to diagnose and manage allergic reactions more accurately.
The test is highly precise and reliable method that quantifies IgE antibodies, providing valuable insights into the severity of the house dust allergic response and guiding further diagnostic and treatment decisions.
The D Pteronsysinus test measures the presence and levels of specific IgE antibodies produced by the immune system in response to allergens from Dermatophagoides Pternonyssinus mites (a common house dust mite). This test helps evaluate the body's immune response to dust mites, which are often found in home environments. Elevated IgE levels in response to these mites indicate an allergic sensitivity, enabling doctors to diagnose and manage allergic reactions more accurately.
The test is a highly precise and reliable method that measures IgE antibodies, providing valuable insights into the severity of the D Pteronsysinus allergic response and guiding further diagnostic and treatment decisions.
The Allergy - Dust Panel, ImmunoCAP is done:
- If you experience allergy symptoms such as itchy or watery eyes, swelling, shortness of breath, skin rash, congestion, hives, eczema, or sneezing.
- If you have allergic asthma.
- To track and monitor treatment effectiveness.
- In individuals with a family history of allergies.
- Clinical history is preferred.






















